BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22479385)

  • 1. Abnormal pulmonary artery stiffness in pulmonary arterial hypertension: in vivo study with intravascular ultrasound.
    Lau EM; Iyer N; Ilsar R; Bailey BP; Adams MR; Celermajer DS
    PLoS One; 2012; 7(3):e33331. PubMed ID: 22479385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary arterial stiffness indices assessed by intravascular ultrasound in children with early pulmonary vascular disease: prediction of advanced disease and mortality during 20-year follow-up.
    Ploegstra MJ; Brokelman JGM; Roos-Hesselink JW; Douwes JM; van Osch-Gevers LM; Hoendermis ES; van den Bosch AE; Witsenburg M; Bartelds B; Hillege HL; Berger RMF
    Eur Heart J Cardiovasc Imaging; 2018 Feb; 19(2):216-224. PubMed ID: 28329155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Application of Intravascular Ultrasound to Evaluate Pulmonary Vascular Properties and Mortality in Patients with Pulmonary Arterial Hypertension.
    Shen JY; Cai ZY; Sun LY; Yang CD; He B
    J Am Soc Echocardiogr; 2016 Feb; 29(2):103-11. PubMed ID: 26443045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary arterial stiffness assessed by cardiovascular magnetic resonance imaging is a predictor of mild pulmonary arterial hypertension.
    Ray JC; Burger C; Mergo P; Safford R; Blackshear J; Austin C; Fairweather D; Heckman MG; Zeiger T; Dubin M; Shapiro B
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1881-1892. PubMed ID: 29934885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of intravascular ultrasound in the assessment of pulmonary vascular properties and mortality in patients with pulmonary artery hypertension associated with connective tissue diseases].
    Cai Z; Li J; Sun L; Yang C; Shen J; He B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Dec; 43(12):1061-7. PubMed ID: 26888841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac magnetic resonance imaging-derived pulmonary artery distensibility index correlates with pulmonary artery stiffness and predicts functional capacity in patients with pulmonary arterial hypertension.
    Kang KW; Chang HJ; Kim YJ; Choi BW; Lee HS; Yang WI; Shim CY; Ha J; Chung N
    Circ J; 2011; 75(9):2244-51. PubMed ID: 21757816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Arterial Remodeling Is Related to the Risk Stratification and Right Ventricular-Pulmonary Arterial Coupling in Patients With Pulmonary Arterial Hypertension.
    Grignola JC; Domingo E; López-Meseguer M; Trujillo P; Bravo C; Pérez-Hoyos S; Roman A
    Front Physiol; 2021; 12():631326. PubMed ID: 34012405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness.
    Stevens GR; Garcia-Alvarez A; Sahni S; Garcia MJ; Fuster V; Sanz J
    JACC Cardiovasc Imaging; 2012 Apr; 5(4):378-87. PubMed ID: 22498327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute absolute vasodilatation is associated with a lower vascular wall stiffness in pulmonary arterial hypertension.
    Grignola JC; Domingo E; Aguilar R; Vázquez M; López-Messeguer M; Bravo C; Roman A
    Int J Cardiol; 2013 Apr; 164(2):227-31. PubMed ID: 21788089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Noninvasive Assessment of Pulmonary Arterial Stiffness Using Velocity Transfer Function.
    Gupta A; Sharifov OF; Lloyd SG; Tallaj JA; Aban I; Dell'italia LJ; Denney TS; Gupta H
    J Am Heart Assoc; 2018 Sep; 7(18):e009459. PubMed ID: 30371198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation.
    Domingo E; Grignola JC; Aguilar R; Messeguer ML; Roman A
    Respir Res; 2017 May; 18(1):85. PubMed ID: 28477618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced haemodynamic coupling and exercise are associated with vascular stiffening in pulmonary arterial hypertension.
    Bellofiore A; Dinges E; Naeije R; Mkrdichian H; Beussink-Nelson L; Bailey M; Cuttica MJ; Sweis R; Runo JR; Keevil JG; Francois CJ; Shah SJ; Chesler NC
    Heart; 2017 Mar; 103(6):421-427. PubMed ID: 27566296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.
    Malhotra R; Dhakal BP; Eisman AS; Pappagianopoulos PP; Dress A; Weiner RB; Baggish AL; Semigran MJ; Lewis GD
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effect of sildenafil is maintained in pulmonary arterial hypertension patients chronically treated with bosentan.
    Hatano M; Yao A; Kinugawa K; Hirata Y; Nagai R
    Int Heart J; 2011; 52(4):233-9. PubMed ID: 21828950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of randomized controlled trials of bosentan for treatment of pulmonary arterial hypertension.
    Lee YH; Song GG
    Korean J Intern Med; 2013 Nov; 28(6):701-7. PubMed ID: 24307846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and metabolic recovery of the right ventricle during Bosentan therapy in idiopathic pulmonary arterial hypertension.
    Spindler M; Schmidt M; Geier O; Sandstede J; Hahn D; Ertl G; Beer M
    J Cardiovasc Magn Reson; 2005; 7(5):853-4. PubMed ID: 16353449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive wave intensity analysis predicts functional worsening in children with pulmonary arterial hypertension.
    Schäfer M; Wilson N; Ivy DD; Ing R; Abman S; Browne LP; Morgan G; Ross M; McLennan D; Barker AJ; Fonseca B; Di Maria M; Hunter KS; Truong U
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H968-H977. PubMed ID: 30004811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of echocardiographic variables of right ventricular function with exercise capacity after bosentan treatment in patients with pulmonary arterial hypertension: Results from a multicenter, prospective, cohort study.
    Kim H; Bae Lee J; Park JH; Yoo BS; Son JW; Yang DH; Lee BR
    J Clin Ultrasound; 2017 Jan; 45(1):28-34. PubMed ID: 27619758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic stability after transitioning between endothelin receptor antagonists in patients with pulmonary arterial hypertension.
    Fox B; Langleben D; Hirsch AM; Schlesinger RD; Eisenberg MJ; Joyal D; Blenkhorn F; Lesenko L
    Can J Cardiol; 2013 Jun; 29(6):672-7. PubMed ID: 22819360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two-years therapy with bosentan of pulmonary arterial hypertension related to connective tissue diseases].
    Marotta H; Montisci R; Tiso F; Pontarollo S; Rizzo M; Tona F; Iliceto S; Cozzi F
    Reumatismo; 2007; 59(4):299-303. PubMed ID: 18157286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.